Search
Patexia Community

Innovation, Technology, and IP News

Is a Patent a Definitive Assurance of Your Idea's Authenticity?

A patent is a legal form of protection granted to inventors for their unique and useful ideas, designs, or products. It gives the patent owner exclusive rights to prevent others from...

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK Personalized Media Communications, LLC v. Apple, Inc., Appeal No. 2021-2275 (Fed. Cir. Jan. 20, 2023) Our Case of the Week focuses on the doctrine of prosecution...

BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda

Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in Mainz, Germany, is scheduled to ship...

Potential Sanctions for Alleged Intellectual Property Theft on the Horizon?

Background On January 5, 2023, President Biden signed into law S. 1294, the “Protecting American Intellectual Property Act of 2022”✎ EditSign. The Act requires the...

Patexia Insight 165: Rise of Judge Albright: The Go-To Judge for Patent Cases and If That Ended in 2022

Next week, our Patent Litigation Intelligence Report will be released. The report covers the five-year period from July 1, 2017, through June 30, 2022, and reviews 18,493 district...

The Positive and Negative Impacts of Patent Litigation on Innovation: A Closer Look

Patent litigation, the process of taking legal action over alleged infringement of a patent, can have a significant impact on innovation. Patents are intended to provide inventors with ...

Feed tagged as "Novartis":
In Novartis AG v. Torrent Pharmaceuticals Limited, [2016-1352] (April 12, 2017), the Federal Circuit affirmed the PTAB’s determination that the challenged... Read More »
International pharmaceutical giant Novartis is suing the United Kingdom's national health system (NHS) for using a cheaper, unlicensed drug instead of... Read More »
CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S... Read More »
  By Toni Clarke               (Reuters) - Biogen Idec Inc's said on Wednesday its experimental... Read More »
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »
  LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the... Read More »
Menu